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30  Human Lymphocytes and sperm cells exposure to MMS produced significant 
31 DNA damage and apoptosis.
32   DNA damage following MMS exposure in vitro was evaluated in the Comet 
33 assay in both cell types.
34  DNA damage and apoptosis resulted in increased P53 and decreased 
35 CDKN1A and BCl-2.
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100 Exposure to DNA-damaging agents produces a range of stress-related responses. 
101 These change the expression of genes leading to mutations that cause cell cycle 
102 arrest, induction of apoptosis and cancer. We have examined the contribution of 
103 haploid and diploid DNA damage and genes involved in the regulation of the 
104 apoptotic process associated with exposure, The Comet assay was used to detect 
105 DNA damage and quantitative RT-PCR analysis (qPCR) to detect gene expression 
106 changes in lymphocytes and sperm in response to methyl methanesulfonate. In the 
107 Comet assay, cells were administered 0-1.2 mM of MMS at 37oC for 30 min for 
108 lymphocytes and 32oC for 60 min for sperm to obtain optimal survival for both cell 
109 types. In the Comet assay a significant increase in Olive tail moment (OTM) and % 
110 tail DNA indicated DNA damage at increasing concentrations compared to the 
111 control group.  In the qPCR study, cells were treated for 4 hr, and RNA was isolated 
112 at the end of the treatment. QPCR analysis of genes associated with DNA stress 
113 responses showed that TP53 and CDKN1A are upregulated, while BCL-2 is 
114 downregulated compared with the control. Thus, MMS caused DNA damage in 
115 lymphocytes at increasing concentrations, but appeared not to have the same effect 
116 in sperm at the low concentrations. These results indicate that exposure to MMS 
117 increased DNA damage and triggered the apoptotic response by activating TP53, 
118 CDKN1A and BCL-2. These findings of the processing of DNA damage in human 
119 lymphocytes and sperm should be taken into account when genotoxic alterations in 






124 1. Introduction 
125 The alkaline Comet assay is widely used for human biomonitoring, ecotoxicology 
126 and routine genotoxicity assessment of chemicals. It has been used extensively to 
127 assess DNA damage as single and double strand breaks and alkali‐labile sites in the 
128 whole genome of the individual cells (Anderson and Plewa, 1998; Tice et al., 
129 2000a).The connections between cell cycle and cell death have been studied and it 
130 has been commonly found that cycling cells are more vulnerable to apoptosis, while 
131 inactive cells are comparatively more resistant to killing (Pucci et al., 2000). It is 
132 known that cancer treatments recruit additional cells into the commonly small growth 
133 fraction of the tumour, so that cells could be vulnerable to chemotherapeutic drugs 
134 (Hardwick and Soane, 2013). Cells treated with the methylating agent methyl 
135 methanesulfonate (MMS) results in alkylated DNA that is badly replicated via DNA 
136 polymerases in vitro and in vivo (Tercero and Diffley, 2001). This DNA damage 
137 induced via genotoxic stress leads to changes in the expression of several critical 
138 genes. The TP53 gene is the most relevant of these genes, also known as tumour 
139 protein 53, which encodes for a 393 amino acid nuclear protein that functions as a 
140 transcription factor p53 (Soussi et al., 1990). The p53 tumour suppressor gene is 
141 important and included in cell cycle regulation, detection and repair of DNA damage, 
142 apoptosis and senescence (Hamzehloie et al., 2012). The ability of p53 to induce 
143 senescence or apoptosis of cells exposed to oncogenic stress establishes a main 
144 pathway by which p53 functions as a tumour suppressor (Pietsch et al., 2008). Over 
145 the past several decades, research has revealed that the p53 protein is superfluous 
146 for normal progress but is essential for cellular response to DNA damage (Liu and 
147 Kulesz-Martin, 2001; Liu et al., 2010a). The activity of p53 is firmly controlled at 
148 insignificant levels in normal cells. p53 protein is rapidly induced by DNA damaging 
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149 stimuli such as UV light, chemical carcinogens and chemotherapeutic agents (Liu 
150 and Kulesz-Martin, 2001; Purvis et al., 2012). The induction of p53 is attained during 
151 a post-translational mechanism which decreases the p53 turnover. This p53 
152 induction plays a crucial role in transcriptional activation of the cell cycle inhibitor p21 
153 and cell cycle arrest (Wulf et al., 2002). The cyclin-dependent kinase (CDK) inhibitor 
154 p21CDKN1A  is mostly controlled at the transcriptional level, while induction of p21 
155 mainly leads to cell cycle arrest (Gartel and Radhakrishnan, 2005). In addition, p21 
156 plays an important role in the inhibition of DNA replication during the proliferation of 
157 the cell nuclear antigen PCNA (Perucca et al., 2006). The level of expression of p21 
158 is up-regulated via the p53 tumour suppressor gene in vitro, in response to DNA-
159 damaging agents (Macleod et al., 1995; Benson et al., 2014). p21 mediates growth 
160 arrest when cells are exposed to DNA damaging agents such as chemotherapy 
161 drugs (Gartel and Radhakrishnan, 2005). Furthermore, p21 expression can be 
162 regulated p53 independently in several situations involving cellular differentiation and 
163 normal tissue development (Liu et al., 2010b). The members of the Bcl-2 family of 
164 proteins are included in the regulation of apoptosis pathways as inducers and 
165 inhibitors in many cell types (Hardwick and Soane, 2013). They are regulated and 
166 mediate the process by which mitochondria contribute to cell death. This pathway is 
167 required for normal embryonic development and for preventing cancer (Hardwick 
168 and Soane, 2013). The Bcl2 protein also has important roles in normal cell 
169 physiology associated with mitochondrial dynamics and other processes of normal 
170 healthy cells (Hardwick and Soane, 2013).
171 In the present study, DNA damage was assessed using the Comet assay. The 
172 expression of the apoptosis regulatory genes, TP53, CDKN1A and BCL2 were 
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173 determined using qPCR methods in somatic and germ cells after MMS treatment of 
174 human lymphocytes and sperm to determine effects in diploid and haploid cells. 
175 2. Materials and Methods
176 2.1. Collection of semen and blood samples 
177 Ethical approval for the collection of semen and blood samples has been provided by 
178 the University of Bradford’s Research Ethics Subcommittee involving human 
179 subjects (reference number: 0405/8). After informed consent, peripheral blood from 
180 four healthy, non-smoking volunteers (average age of 38 ± 6.7 years) was obtained 
181 in heparinised vacutainers (Greiner-Bio-One, Germany) by venepuncture. Also, four 
182 semen samples were provided and consented and each sample was analysed within 
183 2 h after ejaculation according to the WHO criteria (World Health Organization, 1999) 
184 for general appearance, viscosity, volume, pH, sperm concentration, motility and 
185 morphology. After aliquoting, semen samples were snap-frozen in liquid nitrogen and 
186 subsequently stored at −80 ◦C until analysis.
187 2.2. Lymphocyte isolation for the Comet assay
188 Whole blood was diluted 1:1 with saline and lymphocytes were isolated using of 
189 Lymphoprep (Axis-Shield, Norway) according to the manufacturer’s instructions. The 
190 lymphocyte pellet was then resuspended in foetal bovine serum (FBS; Invitrogen, 
191 UK) and transferred to a cryovials containing FBS/DMSO (9:1). This cell suspension 





195  2.3. Cell treatment 
196 Cell suspensions (1 ml, 106 cells/ml) were mixed with fresh Roswell Park Memorial 
197 Institute (RPMI) 1640 Medium (total volume 1000 µl). One hundred μl of cell 
198 suspension were then added to each treatment tube with, 890 μl RPMI medium, plus 
199 10 μl of MMS or RPMI for the negative control). Cells were treated with different 
200 concentrations (0, 0.3, 0.6, 0.8 and 1 mM) of MMS for 30 min at 37 ◦C (lymphocytes) 
201 or for 60 min at 32 ◦C (sperm). The treated and untreated cells were used for the 
202 Comet assay and quantitative reverse transcription PCR (RT-qPCR).
203 2.4. Cell viabilities
204 To prevent the effect of DNA degradation related to cytotoxicity, viability staining of 
205 lymphocytes was performed prior to the experiments (Tice et al., 2000b). For both 
206 lymphocytes and sperm, cell viability was measured by use of the Trypan blue 
207 exclusion test (10 µl of 0.05% Trypan blue added to 10 µl of cell suspension (Pool-
208 Zobel et al., 1992). Viability was generally >90%, but always >75% (Henderson et 
209 al., 1998).  
210 2.5. Comet assay on sperm and lymphocytes 
211 DNA damage was measured with the alkaline version of the Comet assay. In brief, 
212 after treatment, cell samples were centrifuged and the supernatant was discarded. 
213 To the cell pellet 100 μl of 0.5% low melting agarose (LMP) (Invitrogen, Paisley, UK: 
214 15517-022) was added. This cell suspension was transferred to slides pre-coated 
215 with 1% normal melting point (NMP) agarose. For sperm, 2% LMP agarose was 
216 used. The slides were placed on an ice block for 5 min, after which 100 μl of 0.5% 
217 LMP was added on top and slides were placed on ice for another 5 min. When using 
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218 lymphocytes, slides were placed in freshly prepared, cold lysing buffer (2.5 M NaCl, 
219 100 mM EDTA, 10 mM Tris, pH 10, with 1% Triton X-100 and 10% DMSO added just 
220 before use) and kept overnight at 4◦C. For sperm, the lysis solution was 
221 supplemented with 10 mM dithiothreitol (Sigma, UK) and 0.05 g/ml proteinase K 
222 (Sigma, UK), respectively, and incubation took place in each solution for 1 h at 4 ◦C. 
223 The slides were placed on a horizontal gel electrophoresis platform and covered with 
224 an alkaline solution of 300 mM NaOH and 1 mM Na2EDTA, pH ∼13.5) for a pre-
225 incubation prior to electrophoresis. Electrophoresis was carried out for 30 min 
226 (lymphocytes) or 20 min (spermatozoa) at 4 ◦C at ∼0.75 V/cm (20-25V, ∼300 mA). 
227 The DNA was electrophoresed for 20 min and the slides rinsed gently 3 times with 
228 400 mM Tris (pH 7.5) to neutralize the excess alkali. Each slide was stained with 60 
229 μl of 20 µg/ml ethidium bromide (Sigma) and covered with a coverslip. Slides were 
230 analyzed by a computerized image analysis system (Comet 6.0; Andor Technology, 
231 Belfast, UK). In the Comet assay, Olive tail moment and % tail DNA were measured 
232 as DNA damage parameters for sperm and lymphocytes. All of these steps were 
233 conducted under dimmed light to prevent the occurrence of additional DNA damage. 
234 2.6. Isolation of total RNA and cDNA synthesis
235 Total RNA from cells (lymphocytes and sperm) was isolated using TRIzol® following 
236 the manufacturer's (Invitrogen) manual and RNA quantity and quality were checked 
237 by OD260/280 measurements. To remove any genomic DNA, the RNA was treated 
238 with DNase I (Sigma–Aldrich) according to the manufacturer's instructions. Random 
239 hexamer primed reverse transcription reactions were performed for 400 ng of total 
240 RNA in a 20 μl setup using ImProm-II™ Reverse Transcription System reaction 
241 following the manufacturer's instructions (Promega). The synthesised cDNA samples 
242 were diluted 1:10 in nuclease free water and stored at −20 °C.
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243 2.7. Quantitative real-time PCR assay
244 Reactions were carried out using the StepOnePlus™ real-time PCR instrument 
245 (Applied Biosystems). Quantitative real-time PCR was used to quantify the mRNA 
246 expression of TP53, CDKN1A and BCL2 in lymphocytes and sperm. QPCR was 
247 prepared in triplicates of 20 μl reaction mixture in MicroAmp optical 96-well reaction 
248 plates and sealed with optical adhesive covers (Applied Biosystems). Each reaction 
249 well contained 2 μl of template DNA, 2 μl of 10 × SYBR® Green PCR Master Mix 
250 (Applied Biosystems), and 12.5 pmol each of forward and reverse primers. Real-time 
251 qPCR was conducted with the following cycling conditions: 50 °C for 2 min, 95 °C for 
252 20 s, followed by 50 cycles of 95 °C for 15 s and 60 °C for 30 s each. The data 
253 obtained from each reaction was analysed by StepOne™ Software v 2.2.2. Relative 
254 quantification representing the change in gene expression from real-time quantitative 
255 polymerase chain reaction between experimental groups was calculated by the 
256 comparative CT method. The data were analysed by calculating the relative 
257 quantification (RQ) using the equation: RQ = 2-∆CT x100, where ∆CT = CT of target 
258 gene- CT of an endogenous housekeeping gene. Evaluation of 2-∆CT indicates the fold 
259 change in gene expression, normalized to the internal control (β-actin) which enables 
260 the comparison between differently treated cells.
261 3. Results 
262 The responses of human lymphocytes to MMS for the Comet assay parameters 
263 Olive tail moment (OTM) and percent DNA in tail (% tail DNA) are shown in Table 1, 
264 Fig.1 and 2. A significant increase was seen in tail moment and % tail DNA in the 
265 lymphocytes from 5.70 (OTM) and 22.42% (% tail DNA) compared to the untreated 
266 control groups to 1.49 (OTM) 7.65% (% tail DNA), respectively, when cells were 
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267 treated with 0.6 mM MMS. Further increases to 6.97 in (OTM) and 27.57% in (% tail 
268 DNA) were observed when cells were treated with 0.8 mM MMS. At 1.2 mM, in the 
269 OTM and % tail DNA further increased to 11.00 and 36.71% respectively. For sperm, 
270 the corresponding mean tail moments increased from 4.93 in control to 6.28 at 0.3 
271 mM and 8.44 at 0.6 mM. After treatment, significant increases in tail moment of the 
272 nuclei were seen (Table 1, Fig. 1 and 2). This significant increase remained at 
273 approximately the same level in OTM to a final concentration of 1.2 mM MMS. The 
274 same significant MMS induction of DNA damage could also be seen when the % tail 
275 DNA was considered, as increases from 27.98 % in control to 34.68% (at 0.3 mM) 
276 and 39.60% (at 0.6 mM) were observed. Following exposure to 0.8 mM, cells treated 
277 with 0.8 mM MMS showed statistically significant increased % tail DNA damage to 
278 46.61%, when compared with the control. A further increase to 51.15% in % tail DNA 
279 was observed when cells were treated with 1 mM MMS.
280 For the qPCR assay, different levels of expression of TP53, CDKN1A and BCL2 
281 mRNA in lymphocytes were seen after treatment with different concentrations of 
282 MMS. The samples were taken at 4 h following MMS treatment for both treated and 
283 untreated control cultures, and the expression levels of TP53, CDKN1A and BCL2 
284 were normalised against those of β-actin and compared with the equivalent control 
285 value. 
286 Fig. 3 and 4 shows RT-PCR results of different apoptotic genes after lymphocytes 
287 and sperm cells were treated with MMS. When the MMS concentration was 
288 increased from 0 to 1.2 mM, the band intensities for TP53 and CDKN1A were found 
289 to be increased while the intensities for bands of BCL2 were found to be decreased 
290 with the increased MMS concentration. To ensure even loading of the total proteins, 
ACCEPTED MANUSCRIPT
11
291 the β-actin was used. Fig. 3B and 4B show mRNA expression of TP53 and 
292 CDKN1A, and BCL2 in human lymphocytes. The expression levels of these genes 
293 were evaluated by the qPCR.
294 There were statistically significant differences in the levels of TP53 and CDKN1A 
295 after 4h of treatment with 0.3, 0.6, 0.8 mM and 1.2 mM MMS in both lymphocytes 
296 and sperm. However, a significant decrease in the level of expression of BCL2 in 
297 both cell types treated with 0.3, 0.6, 0.8 mM and 1.2 mM MMS (*p 0.05, **p 0.01 and 
298 ***p 0.001) and respectively as shown in Fig. 3 A and B and 4 A and B.
299 4. Discussion 
300 Methyl methanesulfonate was the chemical of choice for the induction of DNA 
301 damage in human lymphocytes and sperm as a well-known genotoxic compound 
302 that can directly react with guanine and adenine bases of DNA to generate 
303 interstrand and intrastrand cross-links (Hosseinimehr et al., 2011). During cell 
304 division, however, the replication fork could be stalled and collapses at the sites of 
305 DNA cross-links, leading to formation and subsequent processing of DNA double 
306 strand-breaks (DSB), which are considered the most deleterious form of DNA 
307 damage (Yu et al., 2006). Through obstructing the structural and functional 
308 properties of DNA, DSBs can have deleterious effects on many aspects of DNA 
309 metabolism, including DNA replication and transcription, and because they can 
310 eventually cause mutations and chromosomal aberrations (Shanbhag et al., 2010; 
311 Polo and Jackson, 2011). Double strand-breaks can also create various signal 
312 transduction pathways that can ultimately result in cell tumorigenesis, to 
313 programmed cell death (Suwaki et al., 2011). These DNA strand breaks inducing 
314 programmed cell death is a crucial event for numerous regular chemotherapeutic 
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315 agent applications (Waxman and Schwartz, 2003). Programmed DNA lesions also 
316 form as intermediates through developmentally regulated genome rearrangements in 
317 germ cells and somatic cells (Longhese et al., 2009; Tsai and Lieber, 2010).The 
318 induction of DNA breaks and the changed expression of the apoptosis regulatory 
319 genes, TP53, CDKN1A and BCL2 by MMS were assessed using the comet and 
320 qPCR assays on human lymphocytes and sperm. For the Comet assay, DNA 
321 damage response patterns for the OTM and % tail DNA Comet-assay parameters 
322 were observed for both cell types (Tables 1 and 2); however, sperm additionally 
323 showed a significant increase in OTM and % tail DNA after being exposed to lower 
324 concentrations of 0.3 mM for both OTM and % tail DNA (Fig.1). MMS genotoxicity on 
325 germ cells has been well studied and described in numerous in vivo studies reporting 
326 the induction of chromatin alterations also dominant lethal mutations and heritable 
327 translocations in sperm (Ehling and Neuhauser-Klaus, 1990; Russell et al., 1992; 
328 Cordelli et al., 2007). This suggests that the damage to the spermatozoa DNA was 
329 potentially introduced by inhibiting replication, causing formation of replication-
330 related to DNA lesions, and potentially DSBs. Late spermatids and immature 
331 spermatozoa are most sensitive to MMS due to the absence of DNA repair during 
332 postmeiotic stages (Inoue et al., 1993). MMS also showed significantly increased 
333 concentration-dependent responses in lymphocytes for the Comet assay 
334 parameters. OTM values significantly increased with the MMS concentration of 0.6 
335 mM. This significant increase continued to stay at approximately the same level up to 
336 concentrations of 0.8 mM and 1.2 mM MMS (Table 1). This positive result is similar 
337 to results of Baohong et al. (2005), where earlier significantly increased incidences of 
338 DNA damage were observed in human lymphocytes after in vitro treatment with 
339 MMS using the Comet assay (Baohong et al., 2005). Our results show that sperm 
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340 reach significance at a lower threshold of sensitivity with lower concentrations of 
341 MMS. This may be due to the fact that they are unable to repair damaged DNA and 
342 they are structurally different. This has been previously shown for other chemicals 
343 (Baumgartner et al., 2012). In another study, it has been reported that DNA damage 
344 was evaluated in human lymphocytes and sperm, highly increased DNA damage in 
345 sperm was observed when compared with the response in lymphocytes using the 
346 alkaline comet assay in vitro (Anderson et al., 2003; Migliore et al., 2006; Pandir, 
347 2015). In contrast to somatic cells, sperm protamines contain a significant number of 
348 cysteine residues which are essential in the last stage of sperm nuclear maturation 
349 as they form protamine disulfide cross bonds (Loir and Lanneau, 1984). This S-
350 methyl-L-cysteine group is the major reaction product after exposure to MMS (Sega 
351 and Owens, 1983). Alkylation of cysteine sulfhydryl groups contained in sperm 
352 protamine blocks normal disulfide bond formation, preventing proper chromatin 
353 condensation in the sperm nucleus. Subsequent stresses produced in the chromatin 
354 structure eventually lead to chromosome breakage, with resultant dominant lethality 
355 (Sega and Owens, 1983). The results also showed that the defective spermatid 
356 protamination and disulphide bridge formation could be attributable to insufficient 
357 oxidation of alkylation groups. This destructively affects sperm chromatin packaging 
358 and creates sperm cells more susceptible to reactive oxygen species (ROS) while 
359 subsequently inducing DNA fragmentation. Lymphocytes, however, seem to be less 
360 susceptible to MMS during the cell cycle. This implies that less damage to the DNA 
361 from lymphocyte was seen due to repair of DNA damage before replication start. 
362 Fast repair of DNA damage was observed in human lymphocytes during the first 
363 hours of cultivation after treatment with MMS using the comet assay (Bausinger and 
364 Speit, 2015). Mammalian cell responses to several stresses fluctuate importantly; 
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365 reliant on the type of cells exposed to stress and time and type of toxicant exposure. 
366 MMS induces apoptosis during the activation of p53-dependent and independent 
367 pathways (Lackinger et al., 2001; Ryu et al., 2001). In agreement with these studies, 
368 our data showed that for both cell types, after 4h treatment with MMS (0.3, 0.6, 0.8 
369 and 1.2 mM), TP53 and CDKN1A were induced and BCL2 expression was 
370 downregulated in a dose-dependent manner. The p53 plays a key role in the 
371 regulation of cell cycle events (Sionov et al., 2000). In response to DNA damage, 
372 p53 is activated and turns on the transcription of one of its important downstream 
373 genes, p21 (el-Deiry et al., 1993). p21 subsequently binds and inhibits, preventing 
374 phosphorylation of important CDK substrates and blocking cell cycle development, so 
375 allowing further time for the cell to repair DNA damage (Ouhtit et al., 2000). Our 
376 findings that MMS induction of TP53 led to the induction of the CDKN1A gene (Fig. 3 
377 and 4) implies that MMS induces TP53, which, in turn, activates CDKN1A and 
378 results in cell cycle arrest to allow the repair of induced DNA damage. These results, 
379 also combined with the disruption of mitochondrial membrane permeabilization, 
380 release of cytochrome c from mitochondria, and downregulation of BLC2, indicate 
381 that the accumulation of DSB contributes to the induction of mitochondria-dependent 
382 cell apoptosis under these experimental conditions. 
383 5. Conclusions
384 The present study reveals the effects of MMS on human somatic cells and germ 
385 cells and provides significant insight into potential mechanisms through which MMS 
386 exerts its genotoxic effects on these cells. In addition to the Comet assay data 
387 evaluation of DNA damage via qPCR data using differential expression analysis of 
388 TP53, CDKN1A and BCL-2 genes have provided the evidence for the genotoxic 
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389 effects of MMS in healthy human lymphocytes and sperm. Thus, the sperm appear 
390 to be more sensitive to MMS. Despite the differences in cell packaging of the two cell 
391 types, they were examined at optimal conditions of survival for both types, so can 
392 more readily be made.
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548 Fig1.  Comet assay results obtained from exposure of 0, 0.3, 0.6, 0.8 and 1.2 mM 
549 concentrations of MMS to lymphocytes and sperm cells. Comet parameters, % tail 
550 DNA were taken into account to measure DNA damage showing a clear  
551 concentrations related increase in DNA damage. All experiments were performed at 
552 least three times. Mean values ± SE. * = comparison with negative control. *P < 
553 0.05, **P < 0.01, ***P < 0.001.
554 Fig 2.  Comet assay results obtained from exposure of 0, 0.3, 0.6, 0.8 and 1.2 mM 
555 concentrations of MMS to lymphocytes and sperm cells. Comet parameters, OTM 
556 were taken into account to measure DNA damage showing a clear concentrations 
557 related increase in DNA damage. All experiments were performed at least three 
558 times. Mean values ± SE. * = comparison with negative control. *P < 0.05, **P < 
559 0.01, ***P < 0.001.
560 Fig 3. Concentration-dependent effects of MMS on TP53, CDKN1A, and BCL-2 
561 mRNA expression levels in lymphocyte cells, treated with different concentrations of 
562 MMS (0, 0.3, 0.6 and 1.2 mM) for 4 h. mRNA expression levels were determined by 
563 qPCR. β-actin mRNA was used as an internal control. (A) The relative gene 
564 expression level of TP53, CDKN1A, and BCL-2, analyzed from the qPCR results. (B) 
565 The mRNA of lysed cells was extracted and was converted to cDNA. The gene 
566 expression levels of TP53, CDKN1A, and BCL-2 were evaluated by reverse-
567 transcription PCR. β-actin mRNA was used as the internal control. The data shown 
568 are representative of three independent experiments. The significant differences 
569 from control are indicated by *P < 0.05, **P < 0.01, ***P < 0.001.
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570 Fig 4. Concentration-dependent effects of MMS on TP53, CDKN1A, and BCL-2 
571 mRNA expression levels in sperm cells, treated with different concentrations of MMS 
572 (0, 0.3, 0.6 and 1.2 mM) for 4 h. mRNA expression levels were determined by qPCR. 
573 β-actin mRNA was used as an internal control. (A) The relative gene expression 
574 level of TP53, CDKN1A, and BCL-2, analyzed from the qPCR results. (B) The mRNA 
575 of lysed cells was extracted and was converted to cDNA. The gene expression levels 
576 of TP53, CDKN1A, and BCL-2 were evaluated by reverse-transcription PCR. β-actin 
577 mRNA was used as the internal control. The data shown are representative of three 
578 independent experiments. The significant differences from control are indicated by 





















598 Table 1. Concentrations-response of MMS in human lymphocytes and sperm was measured 
599 using the alkaline Comet assay with the parameters Olive tail moment (OTM) and % tail 
600 DNA. Data shown represents group values (mean ± SE) of three experiments (100 cells per 









 Exposure concentrations for 
lymphocytes
Olive Tail moment  
Mean ±SE
%Tail DNA  Mean ± 
SE  
Control 1.49 ± 0.14 7.65 ± 0.82
0.3 mM 3.14 ± 0.46 14.97 ± 1.65
0.6 mM 5.71 ± 0.84 * 22.42 ± 2.14 *
0.8 mM 6.97 ± 1.21 ** 27.57 ± 2.36 *
1.2 mM 11.00 ± 1.34 ** 36.71 ± 3.73 **
Exposure concentrations for sperm
Olive Tail moment  
Mean ±SE
%Tail DNA  Mean ± 
SE  
Control 4.93 ± 0.26 27.98 ± 1.69
0.3 mM 6.28 ± 0.44 * 34.68 ± 0.54 *
0.6 mM 8.44 ± 0.58 * 39.66 ± 2.85 **
0.8 mM 10.11 ± 0.43 ** 46.61 ± 2.13 **
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Table 1. Concentration-responses of MMS in human lymphocytes and sperm were measured 
using the alkaline Comet assay with Olive tail moment (OTM) and % tail DNA. Data shown 
represents group values (mean ± SE) of three experiments (100 cells per experiment). Ns not 
significant, *P < 0.05, **P < 0.01, ***P < 0.001 versus control.
Lymphocytes
                            Concentrations Olive Tail moment  Mean ±SE %Tail DNA  Mean ± SE  
Control 1.49 ± 0.14 7.65 ± 0.82
0.3 mM 3.14 ± 0.46 14.97 ± 1.65
0.6 mM 5.71 ± 0.84 * 22.42 ± 2.14 *
0.8 mM 6.97 ± 1.21 ** 27.57 ± 2.36 *
1.2 mM 11.00 ± 1.34 ** 36.71 ± 3.73 **
Sperm
Control 4.93 ± 0.26 27.98 ± 1.69
0.3 mM 6.28 ± 0.44 * 34.68 ± 0.54 *
0.6 mM 8.44 ± 0.58 * 39.66 ± 2.85 **
0.8 mM 10.11 ± 0.43 ** 46.61 ± 2.13 **
1.2 mM 11.58 ± 0.14 *** 51.15 ±3.62 ***
